Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors

NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses

Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182

Brain corticosteroid receptor balance in health and disease

de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614

Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390

A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors

Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150

Steroid hormone receptors: Many Actors in search of a plot

Beato, M., Herrlich, P. A., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,816

Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,676

Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms

Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591

Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,544

Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300

Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210

The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression

De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898

NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis

Roman‐Blas, J. A., & Jiménez, S. A. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.008 · Cited by 701

Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation

Reddy, T. E., Pauli, F., Sprouse, R. O., Neff, N. F., Newberry, K. M., Garabedian, M. J., & Myers, R. M. (2009) · Genome Research · doi:10.1101/gr.097022.109 · Cited by 543

NF-κB in inflammation and cancer

Mao, H., Zhao, X., & Sun, S. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 601

Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection

Silverman, M. N., Pearce, B. D., Biron, C. A., & Miller, A. H. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.41 · Cited by 506

One Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids

Cruz‐Topete, D., & Cidlowski, J. A. (2014) · NeuroImmunoModulation · doi:10.1159/000362724 · Cited by 481

The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders

Hassa, P. O., & Hottiger, M. O. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8527-2 · Cited by 437

Platelet-Rich Plasma Releasate Inhibits Inflammatory Processes in Osteoarthritic Chondrocytes

van Buul, G. M., Koevoet, W. L. M., Kops, N., Bos, P. K., Verhaar, J. A. N., Weinans, H., Bernsen, M. R., & van Osch, G. J. V. M. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511419278 · Cited by 413

Microglia Priming with Aging and Stress

Niraula, A., Sheridan, J. F., & Godbout, J. P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.185 · Cited by 398

The human glucocorticoid receptor: One gene, multiple proteins and diverse responses

Zhou, J., & Cidlowski, J. A. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.006 · Cited by 387

Hepatic inflammation and progressive liver fibrosis in chronic liver disease

Czaja, A. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2515 · Cited by 359

Glucocorticoid‐induced leucine zipper (GILZ): a new important mediator of glucocorticoid action

Ayroldi, E., & Riccardi, C. (2009) · The FASEB Journal · doi:10.1096/fj.09-134684 · Cited by 348

Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis

Karban, A. S., Okazaki, T., Panhuysen, C. I. M., Gallegos, T. F., Potter, J. J., Wilson, J., Silverberg, M. S., Duerr, R. H., Cho, J. H., Gregersen, P. K., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh008 · Cited by 340

Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6

Berghe, W. V., Vermeulen, L., Wilde, G. D., Bosscher, K. D., Boone, E., & Haegeman, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00412-3 · Cited by 302

Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy

Alam, J., Jantan, I., & Bukhari, S. N. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.055 · Cited by 286

Chronic Unpredictable Stress Exacerbates Lipopolysaccharide-Induced Activation of Nuclear Factor-κB in the Frontal Cortex and Hippocampus via Glucocorticoid Secretion

Munhoz, C. D., Lepsch, L. B., Kawamoto, E. M., Malta, M. B., Lima, L. D. S., Werneck Avellar, M. C., Sapolsky, R. M., & Scavone, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4398-05.2006 · Cited by 274

Cortisol response and immune-related effects of Atlantic salmon (Salmo salar Linnaeus) subjected to short- and long-term stress

Fast, M. D., Hosoya, S., Johnson, S. C., & Afonso, L. O. B. (2007) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2007.10.009 · Cited by 285

Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids

Almawi, W., & Melemedjian, O. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280069 · Cited by 242

Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.

Greenstein, S., Ghias, K. K., Krett, N. L., & Rosen, S. T. (2002) · PubMed · Cited by 239

TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL CONTROL OF GENE EXPRESSION IN INFLAMMATION

Kracht, M., & Saklatvala, J. (2002) · Cytokine · doi:10.1006/cyto.2002.0895 · Cited by 229

Multiple Sclerosis: Current Pathophysiological Concepts

Wingerchuk, D. M., Lucchinetti, C. F., & Noseworthy, J. H. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780235 · Cited by 228

Expression of glucocorticoid receptor α- and β-isoforms in human cells and tissues

Pujols, L., Mullol, J., Roca‐Ferrer, J., Torregó, A., Xaubet, A., Cidlowski, J. A., & Picado, C. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00363.2001 · Cited by 224

Mechanisms of the anti‐inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways

Ayroldi, E., Cannarile, L., Migliorati, G., Nocentini, G., Delfino, D. V., & Riccardi, C. (2012) · The FASEB Journal · doi:10.1096/fj.12-216382 · Cited by 207

New and Established Topical Corticosteroids in Dermatology

Brazzini, B., & Pimpinelli, N. (2002) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200203010-00005 · Cited by 193

Defensin Expression by the Cornea: Multiple Signalling Pathways Mediate IL-1β Stimulation of hBD-2 Expression by Human Corneal Epithelial Cells

McDermott, A. M., Redfern, R. L., Zhang, B., Pei, Y., Huang, L. C. L., & Proske, R. J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0787 · Cited by 187

Novel Genomic Effects of Glucocorticoids in Epidermal Keratinocytes

Stojadinović, O., Lee, B., Vouthounis, C., Vukelic, S., Pastar, I., Blumenberg, M., Brem, H., & Tomic‐Canic, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606262200 · Cited by 187

Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner

Munhoz, C. D., Sorrells, S. F., Caso, J. R., Scavone, C., & Sapolsky, R. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0303-09.2010 · Cited by 169

GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling

Ayroldi, E., Zollo, O., Bastianelli, A., Marchetti, C., Agostini, M., Virgilio, R. D., & Riccardi, C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30724 · Cited by 165

Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression

Löwenberg, M., Verhaar, A. P., van den Brink, G. R., & Hommes, D. W. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.001 · Cited by 160

Novel glucocorticoid receptor coactivator effector mechanisms

Jenkins, B. D., Pullen, C. B., & Darimont, B. D. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00357-x · Cited by 150

MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?

Clark, A. R. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780005 · Cited by 148

Characterization of the MM.1 human multiple myeloma (MM) cell lines

Greenstein, S., Krett, N. L., Kurosawa, Y., Ma, C., Chauhan, D., Hideshima, T., Anderson, K. C., & Rosen, S. T. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00023-7 · Cited by 149

Effects of peroxisome proliferator‐activated receptor‐γ agonists on central nervous system inflammation

Kielian, T., & Drew, P. D. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10501 · Cited by 143

Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections

Dijsselbloem, N., Berghe, W. V., Naeyer, A. D., & Haegeman, G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.036 · Cited by 138

Type I Interferon and Systemic Lupus Erythematosus

Elkon, K. B., & Stone, V. V. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0045 · Cited by 131

Glucocorticoids in the regulation of transcription factors that control cytokine synthesis

Liberman, A. C., Druker, J., Perone, M. J., & ARZT, E. S. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.005 · Cited by 126

The activated glucocorticoid receptor inhibits the transcription factor T‐bet by direct protein‐protein interaction

Liberman, A. C., Refojo, D., Druker, J., Toscano, M. A., Rein, T., Holsboer, F., & ARZT, E. S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7452com · Cited by 130

Glucocorticoid receptor recruits to enhancers and drives activation by motif-directed bindingPreprint

McDowell, I. C., Barrera, A., D’Ippolito, A. M., Vockley, C. M., Hong, L. K., Leichter, S. M., Bartelt, L. C., Majoros, W. H., Song, L., Safi, A., et al. (2018) · Genome Research · doi:10.1101/gr.233346.117 · Cited by 126

Corticosterone modulates noradrenaline‐induced melatonin synthesis through inhibition of nuclear factor kappa B

Ferreira, Z., Fernandes, P., Duma, D., Assreuy, J., Avellar, M. C. W., & Markus, R. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00191.x · Cited by 92

Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways

Clark, A. R. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00073-0 · Cited by 117

Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids

Dvořák, Z., & Pávek, P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.484462 · Cited by 116

Effects of stress on the corticolimbic system: implications for chronic pain

Vachon‐Presseau, É. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.014 · Cited by 123

Liposome-Encapsulated Prednisolone Phosphate Inhibits Growth of Established Tumors in Mice

Schiffelers, R. M., Metselaar, J. M., Fens, M. H. A. M., Janssen, A. P. C. A., Molema, G., & Storm, G. (2005) · Neoplasia · doi:10.1593/neo.04340 · Cited by 111

Cyclooxygenase Inhibition as a Strategy to Ameliorate Brain Injury

Hurley, S. D., Olschowka, J. A., & O'Banion, M. K. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753460196 · Cited by 110

Early life immune challenge alters innate immune responses to lipopolysaccharide: implications for host defense as adults

Ellis, S., Mouihate, A., & Pittman, Q. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-3569fje · Cited by 112

Molecular mechanisms of immunomodulatory activity of glucocorticoids

Riccardi, C., Bruscoli, S., & Migliorati, G. (2002) · Pharmacological Research · doi:10.1006/phrs.2002.0969 · Cited by 108

Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression

Muzikar, K. A., Nickols, N. G., & Dervan, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909192106 · Cited by 102

Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-β by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts

詫摩, 敦., Kaneda, T., Sato, T., Ninomiya, S., Kumegawa, M., & Hakeda, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300213200 · Cited by 100

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

Sørensen, P. S., Mellgren, S. I., Svenningsson, A., Elovaara, I., Frederiksen, J. L., Beiske, A. G., Myhr, K., Søgaard, L. V., Olsen, I. C., & Sandberg‐Wollheim, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70085-7 · Cited by 100

Phospholipase A2 subclasses in acute respiratory distress syndrome

Kitsiouli, E., Nakos, G., & Lekka, M. E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.007 · Cited by 100

Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems

Bosscher, K. D., Craenenbroeck, K. V., Meijer, O. C., & Haegeman, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.076 · Cited by 97

Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis

Czaja, A. J., & Carpenter, H. A. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00810.x · Cited by 97

Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus

Orellana, A. M., Vasconcelos, A. R., Leite, J. A., Lima, L. D. S., Andreotti, D. Z., Munhoz, C. D., Kawamoto, E. M., & Scavone, C. (2015) · Aging · doi:10.18632/aging.100853 · Cited by 99

Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis*

Da, J., Chen, L., & Hedenstierna, G. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000250319.91575.bb · Cited by 91

Incidence and Risk Factors of Steroid-induced Diabetes in Patients with Respiratory Disease

Kim, S. Y., Yoo, C., Lee, C. T., Chung, H. S., Kim, Y. W., Han, S. K., Shim, Y.-S., & Yim, J. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.2.264 · Cited by 90

Corticosteroids, Pregnancy, and HELLP Syndrome: A Review

Heimel, P. J. V. R., Franx, A., Schobben, A. F. A. M., Huisjes, A. J. M., Derks, J. B., & Bruinse, H. W. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000150346.42901.07 · Cited by 89

Glucocorticoids inhibitGATA‐3 phosphorylation and activity in T cells

Liberman, A. C., Druker, J., Refojo, D., Holsboer, F., & ARZT, E. S. (2009) · The FASEB Journal · doi:10.1096/fj.08-121236 · Cited by 87

Inhibitors of poly(ADP‐ribose) polymerase‐1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats

Chiarugi, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704934 · Cited by 87

Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis After Liver Transplantation

Czaja, A. J. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2179-3 · Cited by 87

Cachexia: a therapeutic approach beyond cytokine antagonism

von Haehling, S., Genth‐Zotz, S., Anker, S. D., & Volk, H. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00245-0 · Cited by 85

An In Vitro Evaluation of the Anti‐Inflammatory Effects of Platelet‐Rich Plasma, Ketorolac, and Methylprednisolone

Mazzocca, A. D., McCarthy, M. B., Intravia, J. M., Beitzel, K., Apostolakos, J. M., Cote, M. P., Bradley, J., & Arciero, R. A. (2013) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2012.12.005 · Cited by 85

Are Larger Litters a Concern for Piglet Survival or An Effectively Manageable Trait?

Ward, S. A., Kirkwood, R. N., & Plush, K. J. (2020) · Animals · doi:10.3390/ani10020309 · Cited by 84

Recent Advances for Improving Functionality, Biocompatibility, and Longevity of Implantable Medical Devices and Deliverable Drug Delivery Systems

Kutner, N., Kunduru, K. R., Rizik, L., & Farah, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010929 · Cited by 81

Dexamethasone impairs hypoxia-inducible factor-1 function

Wagner, A. E., Huck, G., Stiehl, D. P., JELKMANN, W. E. B., & Hellwig‐Bürgel, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.061 · Cited by 79

Endogenous glucocorticoids protect against TNF-alpha-induced increases in anxiety-like behavior in virally infected mice

Silverman, M. N., MacDougall, M., Hu, F., Pace, T. W. W., Raison, C. L., & Miller, A. H. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001921 · Cited by 78

Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid‐induced leucine zipper? A perspective

Ayroldi, E., Macchiarulo, A., & Riccardi, C. (2014) · The FASEB Journal · doi:10.1096/fj.14-254755 · Cited by 82

Corticosteroids or Not in Severe Acute or Fulminant Autoimmune Hepatitis

Czaja, A. J. (2007) · Liver Transplantation · doi:10.1002/lt.21088 · Cited by 76

Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes

Weikum, E. R., de Vera, I. M. S., Nwachukwu, J. C., Hudson, W. H., Nettles, K. W., Kojetin, D. J., & Ortlund, E. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx509 · Cited by 76

Glucocorticoid‐induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine‐induced COX‐2 expression

Yang, N., Zhang, W., & Shi, X. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21562 · Cited by 76

Corticosteroids as an adjunct to tuberculosis therapy

Schutz, C., Davis, A., Sossen, B., Lai, R., Ntsekhe, M., Harley, Y. X. R., & Wilkinson, R. J. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1515628 · Cited by 73

Orofacial cold hyperalgesia due to infraorbital nerve constriction injury in rats: Reversal by endothelin receptor antagonists but not non-steroidal anti-inflammatory drugs

Chichorro, J. G., Zampronio, A. R., de Souza, G. E. P., & Rae, G. A. (2006) · Pain · doi:10.1016/j.pain.2006.02.010 · Cited by 69

Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB.

Harant, H., & Lindley, I. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh856 · Cited by 77

Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases

Iudicibus, S. D., Stocco, G., Martelossi, S., Londero, M., Ebner, E., Pontillo, A., Lionetti, P., Barabino, A. V., Bartoli, F., Ventura, A., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e8ae93 · Cited by 67

Dexamethasone suppresses interleukin-1β-induced human β-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-κB transcriptional factor in A549 cells

Jang, B., Lim, K.-J., Suh, M., Park, J.-G., & Suh, S. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00293.x · Cited by 63

Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model

Zöller, N. N., Kippenberger, S., Thaçi, D., Mewes, K. R., Spiegel, M., Sättler, A., Schultz, M., Bereiter‐Hahn, J., Kaufmann, R., & Bernd, A. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.022 · Cited by 63

Current and future treatments of autoimmune hepatitis

Czaja, A. J. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.15 · Cited by 65

Trial Watch: Lenalidomide-based immunochemotherapy

Semeraro, M., Vacchelli, E., Eggermont, A. M. M., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.26494 · Cited by 61

Exposure to Repeated, Intermittent d-amphetamine Induces Sensitization of HPA Axis to a Subsequent Stressor

Barr, A. M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00308-6 · Cited by 59

Effect of Corticosteroids and Neuropeptides on the Expression of Defensins in Bovine Tracheal Epithelial Cells

Mitchell, G. B., Al‐Haddawi, M., Clark, M. E., Beveridge, J. D., & Caswell, J. (2006) · Infection and Immunity · doi:10.1128/iai.00686-06 · Cited by 59

Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis

Czaja, A. J., & Montaño‐Loza, A. J. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5351-6 · Cited by 59

Glucocorticoid-independent Repression of Tumor Necrosis Factor (TNF) α-stimulated Interleukin (IL)-6 Expression by the Glucocorticoid Receptor

Verhoog, N. J. D., Toit, A. D., Avenant, C., & Hapgood, J. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193672 · Cited by 56

The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy

Olivry, T., & Sousa, C. A. (2001) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(01)00314-2 · Cited by 57

Neuroendocrine-Immune Interactions in Rheumatoid Arthritis: Mechanisms of Glucocorticoid Resistance

Silverman, M. N., & Sternberg, E. M. (2008) · NeuroImmunoModulation · doi:10.1159/000135620 · Cited by 57

Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial

Lv, Q., Gu, X., Chen, Q., Yu, J., & Zheng, R. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.06.004 · Cited by 56

Inhibition of Inflammatory Cytokine Production in Human Corneal Cells by Dexamethasone, but Not Cyclosporin

Djalilian, A. R., Nagineni, C. N., Mahesh, S. P., Smith, J. A., Nussenblatt, R. B., & Hooks, J. J. (2006) · Cornea · doi:10.1097/01.ico.0000208815.02120.90 · Cited by 53

REV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor

Okabe, T., Chavan, R., Costa, S. S., Brenna, A., Ripperger, J. A., & Albrecht, U. (2016) · Journal of Cell Science · doi:10.1242/jcs.190959 · Cited by 54

Short‐term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population‐based case‐crossover study

Tseng, C., Chen, Y., Huang, C., Luo, J., Peng, Y., Huang, D.-F., Hou, M., Lin, H., & Lee, F. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13298 · Cited by 53

Targeting NF-κB: A Promising Molecular Therapy in Inflammatory Arthritis

Roman‐Blas, J. A., & Jiménez, S. A. (2008) · International Reviews of Immunology · doi:10.1080/08830180802295740 · Cited by 50

Upregulations of Glucocorticoid-Induced Leucine Zipper by Hypoxia and Glucocorticoid Inhibit Proinflammatory Cytokines under Hypoxic Conditions in Macrophages

Wang, Y., Ma, Y.-Y., Song, X.-L., Cai, H., Chen, J., Song, L., Yang, R., & Lu, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002958 · Cited by 52

The Characteristic Long-Term Upregulation of Hippocampal NF-κB Complex in PTSD-Like Behavioral Stress Response Is Normalized by High-Dose Corticosterone and Pyrrolidine Dithiocarbamate Administered Immediately after Exposure

Cohen, H., Kozlovsky, N., Matar, M. A., Zohar, J., & Kaplan, Z. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.118 · Cited by 49

Mode of Glucocorticoid Actions in Airway Disease

Ito, K., Getting, S., & Charron, C. E. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.274 · Cited by 48

Expression of the glucocorticoid receptor is decreased in experimental Staphylococcus aureus sepsis

Bergquist, M., Nurkkala, M., Rylander, C., Kristiansson, E., Hedenstierna, G., & Lindholm, C. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.07.028 · Cited by 49

Drug choices in autoimmune hepatitis: Part B – nonsteroids

Czaja, A. J. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.38 · Cited by 48

Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells

Koubovec, D., Berghe, W. V., Vermeulen, L., Haegeman, G., & Hapgood, J. P. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.03.006 · Cited by 47

Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis

Liu, X., Scheerder, I. D., & Desmet, W. (2004) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2.5.653 · Cited by 47

Differential Gene Expression in Atlantic Salmon Infected with Lepeophtheirus salmonis

Fast, M. D., Ross, N. W., Muise, D. M., & Johnson, S. C. (2006) · Journal of Aquatic Animal Health · doi:10.1577/h05-043.1 · Cited by 46

Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean

Noti, M., Sidler, D., & Brunner, T. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0159-2 · Cited by 44

Glucocorticoids Alter the Lipid and Protein Composition of Membrane Rafts of a Murine T Cell Hybridoma

Laethem, F. V., Liang, X., Andris, F., Urbain, J., Vandenbranden, M., Ruysschaert, J., Resh, M. D., Stulnig, T. M., & Léo, O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2932 · Cited by 44

The HPA Axis and the Immune System

Dunn, A. J. (2007) · Neuroimmune biology · doi:10.1016/s1567-7443(07)00201-3 · Cited by 45

c-Myb and Members of the c-Ets Family of Transcription Factors Act as Molecular Switches to Mediate Opposite Steroid Regulation of the Human Glucocorticoid Receptor 1A Promoter

Geng, C.-D., & Vedeckis, W. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508245200 · Cited by 43

Repression of transcription factor NF-[kappa]B by glucocorticoids : a molecular mechanism for their anti-inflammatory and immuno-modulatory effects

Lidén, J. (2000) · Figshare

Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids

Almawi, W., & Melemedjian, O. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280069 · Cited by 242

The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression

De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898

Nuclear Factor-κ B Repression in Antiinflammation and Immunosuppression by Glucocorticoids

van der Burg, B., Lidén, J., Okret, S., Delaunay, F., Wissink, S., van der Saag, P. T., & Gustafsson, J.-Α. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00006-4 · Cited by 58

Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390